{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:31:46Z","timestamp":1791919906736,"version":"4.3.4"},"reference-count":114,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Human cytomegalovirus (HCMV) is a pathogen with high prevalence in the general population that is responsible for high morbidity and mortality in immunocompromised individuals and newborns, while remaining mainly asymptomatic in healthy individuals. The HCMV genome is 236,000 nucleotides long and encodes approximately 200 genes in more than 170 open reading frames, with the highest rate of genetic polymorphisms occurring in the envelope glycoproteins. HCMV infection is treated with antiviral drugs such as ganciclovir, valganciclovir, cidofovir, foscarnet, letermovir and maribavir targeting viral enzymes, DNA polymerase, kinase and the terminase complex. One of the obstacles to successful therapy is the emergence of drug resistance, which can be tested phenotypically or by genotyping using Sanger sequencing, which is a widely available but less sensitive method, or next-generation sequencing performed in samples with a lower viral load to detect minority variants, those representing approximately 1% of the population. The prevalence of drug resistance depends on the population tested, as well as the drug, and ranges from no mutations detected to up to almost 50%. A high prevalence of resistance emphasizes the importance of testing the patient whenever resistance is suspected, which requires the development of more sensitive and rapid tests while also highlighting the need for alternative therapeutic targets, strategies and the development of an effective vaccine.<\/jats:p>","DOI":"10.3390\/tropicalmed9020049","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:55:59Z","timestamp":1707976559000},"page":"49","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-8779","authenticated-orcid":false,"given":"Ivana","family":"Grgic","sequence":"first","affiliation":[{"name":"Department of Molecular and Immunological Diagnostic, University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevic\u201d, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3341-957X","authenticated-orcid":false,"given":"Lana","family":"Gorenec","sequence":"additional","affiliation":[{"name":"Department of Molecular and Immunological Diagnostic, University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevic\u201d, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"ref_1","unstructured":"Gupta, M., and Shorman, M. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1111-1_1","article-title":"Overview of Human Cytomegalovirus Pathogenesis","volume":"2244","author":"Fulkerson","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_5","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/rmv.645","article-title":"Human cytomegalovirus tropism for endothelial\/epithelial cells: Scientific background and clinical implications","volume":"20","author":"Revello","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10425179109008433","article-title":"The DNA sequence of the human cytomegalovirus genome","volume":"2","author":"Bankier","year":"1991","journal-title":"DNA Seq."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2221797120","DOI":"10.1073\/pnas.2221797120","article-title":"Genomic and geographical structure of human cytomegalovirus","volume":"120","author":"Charles","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Weisburd","year":"2012","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","article-title":"Genetic content of wild-type human cytomegalovirus","volume":"85","author":"Dolan","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1128\/JVI.00578-15","article-title":"High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination","volume":"89","author":"Sijmons","year":"2015","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/v6031049","article-title":"Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing","volume":"6","author":"Sijmons","year":"2014","journal-title":"Viruses"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/infdis\/jix157","article-title":"Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly from Clinical Specimens","volume":"215","author":"Hage","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.humimm.2004.02.023","article-title":"Genomic variants among human cytomegalovirus (HCMV) clinical isolates: The glycoprotein n (gN) paradigm","volume":"65","author":"Pignatelli","year":"2004","journal-title":"Hum. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/rmv.438","article-title":"Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains","volume":"14","author":"Pignatelli","year":"2004","journal-title":"Rev. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1112645","DOI":"10.3389\/fped.2023.1112645","article-title":"Distribution of CMV envelope glycoprotein, B.; H and N genotypes in infants with congenital cytomegalovirus symptomatic infection","volume":"11","author":"Dong","year":"2023","journal-title":"Front. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.30621\/jbachs.1095228","article-title":"Determination of genotypes in cytomegalovirus (CMV) strains obtained from pediatric and adult immunocompromised patients","volume":"7","author":"Kaynar","year":"2023","journal-title":"J. Basic Clin. Health Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12985-015-0428-8","article-title":"Combined genetic variants of human cytomegalovirus envelope glycoproteins as congenital infection markers","volume":"12","author":"Arcangeletti","year":"2015","journal-title":"Virol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/INF.0b013e31829bb0b9","article-title":"Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection","volume":"32","author":"Pati","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2020057","DOI":"10.4084\/mjhid.2020.057","article-title":"Cytomegalovirus Genotype Distribution among Postnatally Infected Infants: Association of Glycoprotein B, Glycoprotein N and Glycoprotein H Types with CMV-Associated Thrombocytopenia","volume":"12","author":"Hu","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dieamant, D.C., Bonon, S.H., Peres, R.M., Costa, C.R., Albuquerque, D.M., Miranda, E.C., Aranha, F.J., Oliveira-Duarte, G., Fernandes, V.C., and De Souza, C.A. (2013). Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-310"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wang, H.Y., Valencia, S.M., Pfeifer, S.P., Jensen, J.D., Kowalik, T.F., and Permar, S.R. (2021). Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity. Viruses, 13.","DOI":"10.3390\/v13061106"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmi.2023.03.020","article-title":"Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients","volume":"29","author":"Razonable","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Galar, A., Valerio, M., Catal\u00e1n, P., Garc\u00eda-Gonz\u00e1lez, X., Burillo, A., Fern\u00e1ndez-Cruz, A., Zatar\u00e1in, E., Sousa-Casasnovas, I., Anaya, F., and Rodr\u00edguez-Ferrero, M.L. (2021). Valganciclovir\u2014Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship. Antibiotics, 10.","DOI":"10.3390\/antibiotics10010077"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for Transplantation and Cellular Therapy Series: Prevention of Cytomegalovirus Infection and Disease after Hematopoietic Cell Transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant. Cell. Ther."},{"key":"ref_26","unstructured":"Garikapati, S., and Nguyen, M. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jtct.2021.09.010","article-title":"American Society for Transplantation and Cellular Therapy Series: #4-Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation","volume":"27","author":"Yong","year":"2021","journal-title":"Transplant. Cell. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"ofad018","DOI":"10.1093\/ofid\/ofad018","article-title":"Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance","volume":"10","author":"Acquier","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e0240521","DOI":"10.1128\/aac.02405-21","article-title":"New Perspectives on Antimicrobial Agents: Maribavir","volume":"66","author":"Blumberg","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for Refractory Cytomegalovirus Infections with or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial","volume":"75","author":"Avery","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"ofac686","DOI":"10.1093\/ofid\/ofac686","article-title":"Maribavir for Cytomegalovirus Treatment in the Real World-Not a Silver Bullet","volume":"10","author":"Fung","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00277-023-05265-8","article-title":"Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient","volume":"102","author":"Dammann","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/ciy706","article-title":"Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study","volume":"68","author":"Papanicolaou","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/jiaa462","article-title":"Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection","volume":"226","author":"Chou","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1128\/JVI.77.21.11499-11506.2003","article-title":"Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27","volume":"77","author":"Komazin","year":"2003","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ibrahim, D., Byrns, J., Maziarz, E., Alexander, B.D., and Saullo, J.L. (2023). Use of Letermovir for Primary and Secondary Cytomegalovirus Prophylaxis in Abdominal Organ Transplantation: A Single Center Experience. J. Pharm. Pract., 08971900231176430.","DOI":"10.1177\/08971900231176430"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e14147","DOI":"10.1111\/tid.14147","article-title":"Letermovir for pre-emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation","volume":"25","author":"Kaur","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Santos Bravo, M., Tilloy, V., Plault, N., Palomino, S.S., Mosquera, M.M., Navarro Gabriel, M., Fern\u00e1ndez Avil\u00e9s, F., Su\u00e1rez Lled\u00f3, M., Rovira, M., and Moreno, A. (2022). Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.00191-22"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/ajt.15135","article-title":"Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection","volume":"18","author":"Cherrier","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Jung, S., Michel, M., Stamminger, T., and Michel, D. (2019). Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4016-1"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2018.09.003","article-title":"New therapies for human cytomegalovirus infections","volume":"159","author":"Britt","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/infdis\/jiz493","article-title":"Advances in the Development of Therapeutics for Cytomegalovirus Infections","volume":"221","author":"Acosta","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"105696","DOI":"10.1016\/j.antiviral.2023.105696","article-title":"Thioxothiazolo[3,4-a] quinazoline derivatives inhibit the human cytomegalovirus alkaline nuclease","volume":"217","author":"Zhang","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOT.0000000000000541","article-title":"Drug-resistant cytomegalovirus: Clinical implications of specific mutations","volume":"23","author":"Razonable","year":"2018","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"104711","DOI":"10.1016\/j.antiviral.2020.104711","article-title":"Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance","volume":"176","author":"Chou","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_47","unstructured":"Richman, D.D., and Nathanson, N. (2016). Viral Pathogenesis, Academic Press."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Panda, K., Parashar, D., and Viswanathan, R. (2023). An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection. Viruses, 15.","DOI":"10.3390\/v15061358"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"04549","DOI":"10.1016\/j.antiviral.2019.104549","article-title":"In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products","volume":"169","author":"Komatsu","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.78.13.7124-7130.2004","article-title":"Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir","volume":"78","author":"Chou","year":"2004","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2013.01.003","article-title":"Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation","volume":"57","author":"Wolf","year":"2013","journal-title":"J. Clin. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.csbj.2015.01.003","article-title":"Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients","volume":"13","author":"Hamprecht","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.04.002","article-title":"Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance","volume":"131","author":"Fischer","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chae, S., Kim, H.S., Cho, S.Y., Nho, D., Lee, R., Lee, D.G., Kim, M., and Kim, Y. (2023). Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients. Viruses, 15.","DOI":"10.3390\/v15061286"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.49.7.2710-2715.2005","article-title":"Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene","volume":"49","author":"Chou","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Mallory, M.A., Hymas, W.C., Simmon, K.E., Pyne, M.T., Stevenson, J.B., Barker, A.P., Hillyard, D.R., and Hanson, K.E. (2023). Development and validation of a next-generation sequencing assay with open-access analysis software for detecting resistance-associated mutations in CMV. J. Clin. Microbiol., 61.","DOI":"10.1128\/jcm.00829-23"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/JCM.00611-13","article-title":"Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples","volume":"51","author":"Castor","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100039","DOI":"10.1016\/j.clinpr.2020.100039","article-title":"Letermovir salvage therapy in the management of a case of cytomegalovirus ventriculitis complicated by drug resistance","volume":"7","author":"Bosworth","year":"2020","journal-title":"Clin. Infect. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QCO.0000000000000936","article-title":"Sequence-based diagnostics and precision medicine in bacterial and viral infections: From bench to bedside","volume":"36","author":"Pham","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.17691\/stm2023.15.2.04","article-title":"NGS Technology in Monitoring the Genetic Diversity of Cytomegalovirus Strains","volume":"15","author":"Vankova","year":"2023","journal-title":"Sovrem. Tekhnologii Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1128\/AAC.00802-10","article-title":"Improved detection of mutated human cytomegalovirus UL97 by pyrosequencing","volume":"54","author":"Schindele","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Li, K.K., Lau, B., Su\u00e1rez, N.M., Camiolo, S., Gunson, R., Davison, A.J., and Orton, R.J. (2023). Direct Nanopore Sequencing of Human Cytomegalovirus Genomes from High-Viral-Load Clinical Samples. Viruses, 15.","DOI":"10.3390\/v15061248"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2016.04.017","article-title":"Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients","volume":"80","author":"Garrigue","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"105520","DOI":"10.1016\/j.jcv.2023.105520","article-title":"Clinical next-generation sequencing assay combining full-length gene amplification and shotgun sequencing for the detection of CMV drug resistance mutations","volume":"165","author":"Caldera","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Streck, N.T., Espy, M.J., Ferber, M.J., Klee, E.W., Razonable, R.R., Gonzalez, D., Sayada, C., Heaton, P.R., Chou, S., and Binnicker, M.J. (2023). Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus. J. Clin. Microbiol., 61.","DOI":"10.1128\/jcm.00429-23"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"105556","DOI":"10.1016\/j.jcv.2023.105556","article-title":"Application of the ViroKey\u00ae SQ FLEX assay for detection of cytomegalovirus antiviral resistance","volume":"167","author":"Hume","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"05623","DOI":"10.1016\/j.antiviral.2023.105623","article-title":"Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients","volume":"215","author":"Kleiboeker","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmii.2021.01.007","article-title":"Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan","volume":"54","author":"Yang","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jfma.2011.08.025","article-title":"Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan","volume":"111","author":"Shao","year":"2012","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-3062.2010.00584.x","article-title":"Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients","volume":"13","author":"Iwasenko","year":"2011","journal-title":"Transpl. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12985-023-02127-7","article-title":"Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance","volume":"20","author":"Recio","year":"2023","journal-title":"Virol. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"105549","DOI":"10.1016\/j.jcv.2023.105549","article-title":"Epidemiology of cytomegalovirus antiviral resistance testing for solid organ and bone marrow transplant patients from 2011\u20132019","volume":"166","author":"Li","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2016.10.016","article-title":"Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study","volume":"138","author":"Campos","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tid.12537","article-title":"Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: A single-center retrospective cohort study","volume":"18","author":"Young","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2017.03.014","article-title":"Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance","volume":"90","author":"Guiu","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/jac\/dkz196","article-title":"Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands","volume":"74","author":"Blokzijl","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: A French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e14070","DOI":"10.1111\/tid.14070","article-title":"Epidemiology, management, and burden of cytomegalovirus in solid organ transplant recipients in selected countries outside of Europe and North America: A systematic review","volume":"25","author":"Tokat","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.3389\/ti.2023.11295","article-title":"Factors Associated with Genotypic Resistance and Outcome among Solid Organ Transplant Recipients with Refractory Cytomegalovirus Infection","volume":"36","author":"Tamzali","year":"2023","journal-title":"Transpl. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31821fad25","article-title":"Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients","volume":"92","author":"Myhre","year":"2011","journal-title":"Transplantation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9636897231195245","DOI":"10.1177\/09636897231195245","article-title":"Research for Cytomegalovirus Mutations Associated with Resistance to Antivirals in Kidney Transplant Receptors","volume":"32","author":"Migone","year":"2023","journal-title":"Cell Transplant."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.healun.2019.09.005","article-title":"Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes","volume":"38","author":"Husain","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"102805","DOI":"10.1016\/j.bjid.2023.102805","article-title":"Efficacy and safety of preemptive therapy for cytomegalovirus end-organ disease in people living with HIV: A systematic review and meta-analysis","volume":"27","year":"2023","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_84","unstructured":"Frost, K.R. (1996). Cytomegalovirus resistance. Public health implications of CMV prophylaxis and treatment in the HIV patient population. AMFAR Rep., 1\u20136."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2010.10.018","article-title":"Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture","volume":"151","author":"Jabs","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"104012","DOI":"10.1016\/j.micpath.2020.104012","article-title":"Global estimate of phenotypic and genotypic ganciclovir resistance in cytomegalovirus infections among HIV and organ transplant patients; A systematic review and meta-analysis","volume":"141","author":"Azimi","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000471484","article-title":"Frequent pUL27 Variations in HIV-Infected Patients","volume":"59","author":"Mirarab","year":"2016","journal-title":"Intervirology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jcv.2013.04.004","article-title":"Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection","volume":"57","author":"Choi","year":"2013","journal-title":"J. Clin. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Morillo-Gutierrez, B., Waugh, S., Pickering, A., Flood, T., and Emonts, M. (2017). Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: A case report and review of the literature. BMC Pediatr., 17.","DOI":"10.1186\/s12887-017-0933-6"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/517468","article-title":"Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency","volume":"178","author":"Wolf","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.mph.0000135283.77668.6a","article-title":"Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency","volume":"26","author":"Blackman","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-010-0181-y","article-title":"Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection","volume":"200","author":"Kampmann","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcv.2012.01.020","article-title":"Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection","volume":"54","author":"Campanini","year":"2012","journal-title":"J. Clin. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/08880018.2019.1695031","article-title":"Cytomegalovirus viremia and resistance patterns in immunocompromised children: An 11-year experience","volume":"37","author":"Kim","year":"2020","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Andouard, D., Tilloy, V., Ribot, E., Mayeras, M., Diaz-Gonzalez, D., El Hamel, C., Piras-Douce, F., Mantel, N., and Alain, S. (2023). Genetic and Functional Characterization of Congenital HCMV Clinical Strains in ex vivo First Trimester Placental Model. Pathogens, 12.","DOI":"10.3390\/pathogens12080985"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Renzette, N., Bhattacharjee, B., Jensen, J.D., Gibson, L., and Kowalik, T.F. (2011). Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001344"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1180392","DOI":"10.3389\/fped.2023.1180392","article-title":"Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: A diagnostic and therapeutic approach to antiviral resistance","volume":"11","author":"Hume","year":"2023","journal-title":"Front. Pediatr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"105422","DOI":"10.1016\/j.antiviral.2022.105422","article-title":"Relative frequency of cytomegalovirus UL56 gene mutations detected in genotypic letermovir resistance testing","volume":"207","author":"Chou","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41409-023-01920-w","article-title":"Cytomegalovirus breakthrough and resistance during letermovir prophylaxis","volume":"58","author":"Perchetti","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"105361","DOI":"10.1016\/j.antiviral.2022.105361","article-title":"First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure","volume":"204","author":"Muller","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.10.019","article-title":"A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance","volume":"148","author":"Chou","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"469","DOI":"10.34172\/apb.2023.046","article-title":"Virus-Specific T Cells: Promising Adoptive T Cell Therapy against Infectious Diseases following Hematopoietic Stem Cell Transplantation","volume":"13","author":"Jalili","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Cho, S.Y., Lee, D.G., and Kim, H.J. (2019). Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112666"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.7150\/ijbs.58127","article-title":"Insight for Immunotherapy of HCMV Infection","volume":"17","author":"Long","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.tim.2022.12.003","article-title":"Novel monoclonal antibody-based therapies: Implications for the treatment and prevention of HCMV disease","volume":"31","author":"Mancebo","year":"2023","journal-title":"Trends Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Ai, Y., Wu, C., Zhang, M., Jaijyan, D.K., Liu, T., Zan, L., Li, N., Yu, W., Wang, Y., and Yuan, X. (2022). Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.01393-22"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Scarpini, S., Morigi, F., Betti, L., Dondi, A., Biagi, C., and Lanari, M. (2021). Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice. Vaccines, 9.","DOI":"10.3390\/vaccines9060551"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.vaccine.2022.07.026","article-title":"Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level","volume":"40","author":"Byrne","year":"2022","journal-title":"Vaccine"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1080\/21645515.2019.1593729","article-title":"Development of novel vaccines against human cytomegalovirus","volume":"15","author":"Cui","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2019","journal-title":"Vaccine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(23)00343-2","article-title":"Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: A double-blind, randomised, placebo-controlled, phase 2b trial","volume":"23","author":"Das","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-018-0074-4","article-title":"A new era in cytomegalovirus vaccinology: Considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection","volume":"3","author":"Nelson","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-virology-100220-010653","article-title":"Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development","volume":"9","author":"Hu","year":"2022","journal-title":"Annu. Rev. Virol."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/9\/2\/49\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:59:58Z","timestamp":1760104798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/9\/2\/49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":114,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["tropicalmed9020049"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed9020049","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}